apoptosis resistance
Showing 1 - 25 of 8,921
Idiopathic Pulmonary Fibrosis Trial in Birmingham (Venetoclax)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
-
Birmingham, AlabamaA. Brent Carter
Aug 3, 2023
Locally Advanced Cervical Cancer Trial in Mexico City (Curcumin, Curcumin + Piperine)
Recruiting
- Locally Advanced Cervical Cancer
- Curcumin
- Curcumin + Piperine
-
Mexico City, MexicoInstituto Nacional de Cancerología
Oct 6, 2023
Oxidative Stress and Mitochondrial TERT in Papillary Thyroid
Recruiting
- Papillary Thyroid Cancer
-
Milan, ItalyIstituto Auxologico Italiano
Mar 2, 2023
Drug-Induced Nephropathy Trial in Cairo (N Acetylcysteine)
Recruiting
- Drug-Induced Nephropathy
- N Acetylcysteine
-
Cairo, EgyptHelwan University
Nov 7, 2023
Beta Cell Dysfunction Trial in Shanghai (overexpression STRA6/miRNA3)
Completed
- Beta Cell Dysfunction
- overexpression STRA6/miRNA3
-
Shanghai, Shanghai, ChinaXiaoyun Cheng
Oct 8, 2022
Fatty Liver Disease Trial (Empagliflozin 10 MG)
Not yet recruiting
- Fatty Liver Disease
- Empagliflozin 10 MG
- (no location specified)
Jan 19, 2023
Mitochondrial DNA Copy Number and Leukocyte Telomere Length as
Recruiting
- Type 2 Diabetes Mellitus
- Genotyping
-
Sohag, EgyptSohag Univversity
Jan 12, 2023
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- Metastatic Malignant Solid Neoplasm
- Biopsy
- +3 more
- (no location specified)
Jan 18, 2023
Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver Disease, Metabolic Syndrome Trial in New York (Metformin, Placebo)
Active, not recruiting
- Polycystic Ovary Syndrome
- +2 more
- Metformin
- Placebo
-
New York, New YorkColumbia University Medical Center
Jul 19, 2022
Colon Cancer Trial in Slagelse (Metformin Hydrochloride, Placebo oral capsule)
Completed
- Colon Cancer
- Metformin Hydrochloride
- Placebo oral capsule
-
Slagelse, DenmarkDepartment of Surgery, Slagelse Hospital
Mar 2, 2022
Schizophrenia Trial in Istanbul (GFAP, S100B)
Recruiting
- Schizophrenia
- GFAP, S100B
-
Istanbul, TurkeyT.C. Sağlik Bilimleri Üniversitesi
Mar 28, 2022
Subclinical Impairment of Cardiovascular System in Psoriasis
Completed
- Psoriasis
- +6 more
-
Ljubljana, SloveniaUniversity Medical Centre Ljubljana
Jul 19, 2023
Recurrent Refractory Mantle Cell Lymphoma
Recruiting
- Mantle Cell Lymphoma
-
Beijing, Beijing, ChinaPeking University Third Hospital
Aug 1, 2022
Schistosoma Related Bladder Diseases.
Not yet recruiting
- Schistosoma Haematobium
- Immunohistochemistry staining,
- microscopic examination of urine
-
Assiut, EgyptAssiut University Hospital
Jul 4, 2023
Serum Insulin-like Growth Factor Binding Protein-3 asPotential
Not yet recruiting
- Colorectal Cancer
- evaluation of diagnostic importance of insulin like growth factor binding protein3 in patient with recently diagnosed as Colorectal cancer
- (no location specified)
May 6, 2023
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)
Not yet recruiting
- Multiple Myeloma in Relapse
- Multiple Myeloma, Refractory
- (no location specified)
Oct 30, 2023
circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC
Not yet recruiting
- Hepatic Cell Carcinoma
- (no location specified)
Sep 12, 2023
Distinguishing Bacterial and Viral Infections by MeMed BV® Test
Recruiting
- Viral Infection
- +3 more
- MeMed BV®
-
Attiki, Chaidari, Greece
- +1 more
Jun 1, 2023
Metastatic Colorectal Cancer Trial in Tanta (Silymarin)
Not yet recruiting
- Metastatic Colorectal Cancer
-
Tanta, Egyptfaculty of Pharmacy , Tanta University
Dec 8, 2022
Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung
Active, not recruiting
- Advanced Lung Non-Squamous Non-Small Cell Carcinoma
- +5 more
-
Sacramento, California
- +17 more
Aug 2, 2022
Prostate Cancer Trial in Baltimore (Enoblituzumab, Standard of Care)
Not yet recruiting
- Prostate Cancer
- Enoblituzumab
- Standard of Care
-
Baltimore, MarylandJohns Hopkins Sidney Kimmel Comprehensive Cancer Center
Aug 25, 2023
Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate
Not yet recruiting
- Cancer of Cervix
- Apoptosis
- Immunohistochemistry
- (no location specified)
Nov 17, 2023